RankingsPricing
  1. JP-listed companies
  2. Takeda Pharmaceutical Company Limited
  3. Financials
  4. Cash from investing

Takeda Pharmaceutical Company Limited【JP:4502】

Market cap
¥8.08T
P/E ratio
52.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2025-367,060-20.87%
Mar 31, 2024-463,862-23.59%
Mar 31, 2023-607,102+206.42%
Mar 31, 2022-198,125-150.35%
Mar 31, 2021393,530+34.72%
Mar 31, 2020292,119-110.30%
Mar 31, 2019-2,835,698+2937.97%
Mar 31, 2018-93,342-85.76%
Mar 31, 2017-655,691+820.81%
Mar 31, 2016-71,208-177.95%
Mar 31, 201591,347-159.29%
Mar 31, 2014-154,057+22.48%
Mar 31, 2013-125,778

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)